Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Bold refers to %Comparison of Low bone mass risk factors in fractured and non-fractured OI patientsFracturesN = 12No fractureN = 38pSmoking (%)2/12 (16.7)10/29 (34.5)0.45BMI < 19 kg/m2 (%)2/10 (20)2/29 (6.9)0.27Corticosteroids (%)01/29 (3.4)1Osteoporosis inducing diseaseSpondyloarthritis1/12 (8.3)00.2Inflammatory bowel disease1/12 (8.3)00.2Anorexia1/12 (8.3)1/29 (3.4)0.50Rheumatoid arthritis01/29 (3.4)1.0Immobilization3/10 (30.0)3/29 (10.3)0.1625OHD < 30 ng/ml (%)2/10 (20.0)13/27 (48.1)0.15Low calcium intake (%)1/12 (8.3)1/29 (3.4)0.50Spine BMD (Z-score)− 2.93 ± 1.57− 1.48 ± 1.670.03Femoral neck BMD (Z-score)− 2.25 ± 0.90− 0.7 ± 1.190.09Total hip BMD (Z-score)− 2.05 ± 0.74− 0.53 ± 1.360.04At least 1 risk factor, %9/11 (81.8)17/29 (58.6)0.2725OHD: 25-hydroxyvitamin D; BMD: Bone mineral density;Comparison of Pregnancy and lactation-related factors in fractured and non-fractured OI patientsFracturesN = 12No fractureN = 38pAge (years; mean ± SD)32.7 ± 3.129.3 ± 5.00.002Number of pregnancies (mean ± SD)0.5 ± 0.90.6 ± 0.80.6Time since last pregnancy (years, mean ± SD)4.1 ± 2.74.4 ± 2.00.51Duration of lactation after previous pregnancy (months, mean ± SD)5.5 ± 8.62.55 ± 4.80.86Breastfeeding (yes, %)*12/14 (85.7%)Including 100% of patients with post-partum fractures25/53 (47.1%)0.03* For pregnancy-related factors, data presented are the number of occurrence of each variable (e.g. breastfeeding) on the total number of pregnancies in each group

Source: Clinical characteristics comparison of fractured and non-fractured OI patients (Tables 3, 4, 5). View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

We performed a retrospective cohort study including women with a clinical diagnosis of OI assessed in Rheumatology department, Cochin Hospital, between January 2006 and December 2019.

Source: Methods.

Among the 63 women identified, 4 patients were excluded because they actually had other genetic causes of bone fragility (osteoporosis-pseudoglioma, and other rare bone diseases), and 9 were excluded because of insufficient data.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Osteogenesis Imperfecta: characterization of fractures during pregnancy and post-partum

Cohort study · Orphanet Journal of Rare Diseases · 2022

Original publication title

Osteogenesis Imperfecta: characterization of fractures during pregnancy and post-partum

Eugénie Koumakis; Valérie Cormier-Daire; Azeddine Dellal; Marc Debernardi; Bernard Cortet; Françoise Debiais; Rose-Marie Javier; Thierry Thomas; Nadia Mehsen-Cetre; Martine Cohen-Solal; Elisabeth Fontanges; Michel Laroche; Valérie Porquet-Bordes; Christian Marcelli; Alexandra Benachi; Karine Briot; Christian Roux; Catherine Cormier

© The Author(s) 2022

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

OI management during pregnancy and post-partum should aim for optimal control of modifiable osteoporosis risk factors, particularly in patients with low BMD. Breastfeeding should be avoided.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Pregnancy and breastfeeding are associated with bone density loss. Fracture occurrence during pregnancy and post-partum, and its determinants, remain poorly known in Osteogenesis Imperfecta (OI). The aim of this study was to characterize fractures that occurred during pregnancy and post-partum in OI patients.

Source: Background

Abstract: Results

We conducted a retrospective multicentric study including a total of 50 previously pregnant OI women from 10 Bone Centers in France. Among these patients, 12 (24%) patients experienced fractures during pregnancy or in the 6 months following delivery, and 38 (76%) did not experience any fracture. The most frequent localizations were: proximal femur (25%), spine (25%), distal femur (12.5%), and pelvis (12.5%). Fractures during pregnancy occurred during the third trimester and post-partum fractures occurred with a mean delay of 2 months following delivery.

No fractures occurred during childbirth.

We next compared the 12 patients with pregnancy or post-partum fractures with the 38 patients without fractures. Mean age at pregnancy was 32.7 ± 3.1 years-old in the fractured group, vs 29.3 ± 5.0 years-old in the non-fractured group (p = 0.002). Breastfeeding was reported in 85.7% of patients in the fractured group, vs 47.1% in the non-fractured group (p = 0.03). All patients with post-partum fractures were breastfeeding. Bone mineral density was significantly lower in patients with pregnancy-related fractures compared with other patients: spine Z-score − 2.9 ± 1.6DS vs − 1.5 ± 1.7DS (p = 0.03), and total hip Z-score − 2.0 ± 0.7DS vs − 0.5 ± 1.4DS (p = 0.04).

At least one osteoporosis-inducing risk factor or disease other than OI was identified in 81.8% vs 58.6% of fractured vs non-fractured patients (not significant). Fracture during pregnancy or post-partum was not associated with the severity of OI. Bisphosphonates before pregnancy were reported in 16.7% and 21.1% of patients with pregnancy-related fractures and non-fractured patients, respectively (not significant).

Source: Results Source: Results

Abstract: Conclusions

OI management during pregnancy and post-partum should aim for optimal control of modifiable osteoporosis risk factors, particularly in patients with low BMD. Breastfeeding should be avoided.

Source: Conclusions
Authors’ abstract

Background

Pregnancy and breastfeeding are associated with bone density loss. Fracture occurrence during pregnancy and post-partum, and its determinants, remain poorly known in Osteogenesis Imperfecta (OI). The aim of this study was to characterize fractures that occurred during pregnancy and post-partum in OI patients.

Results

We conducted a retrospective multicentric study including a total of 50 previously pregnant OI women from 10 Bone Centers in France. Among these patients, 12 (24%) patients experienced fractures during pregnancy or in the 6 months following delivery, and 38 (76%) did not experience any fracture. The most frequent localizations were: proximal femur (25%), spine (25%), distal femur (12.5%), and pelvis (12.5%). Fractures during pregnancy occurred during the third trimester and post-partum fractures occurred with a mean delay of 2 months following delivery.

No fractures occurred during childbirth.

We next compared the 12 patients with pregnancy or post-partum fractures with the 38 patients without fractures. Mean age at pregnancy was 32.7 ± 3.1 years-old in the fractured group, vs 29.3 ± 5.0 years-old in the non-fractured group (p = 0.002). Breastfeeding was reported in 85.7% of patients in the fractured group, vs 47.1% in the non-fractured group (p = 0.03). All patients with post-partum fractures were breastfeeding. Bone mineral density was significantly lower in patients with pregnancy-related fractures compared with other patients: spine Z-score − 2.9 ± 1.6DS vs − 1.5 ± 1.7DS (p = 0.03), and total hip Z-score − 2.0 ± 0.7DS vs − 0.5 ± 1.4DS (p = 0.04).

At least one osteoporosis-inducing risk factor or disease other than OI was identified in 81.8% vs 58.6% of fractured vs non-fractured patients (not significant). Fracture during pregnancy or post-partum was not associated with the severity of OI. Bisphosphonates before pregnancy were reported in 16.7% and 21.1% of patients with pregnancy-related fractures and non-fractured patients, respectively (not significant).

Conclusions

OI management during pregnancy and post-partum should aim for optimal control of modifiable osteoporosis risk factors, particularly in patients with low BMD. Breastfeeding should be avoided.

Publication and source details

Original title: Osteogenesis Imperfecta: characterization of fractures during pregnancy and post-partum

Eugénie Koumakis; Valérie Cormier-Daire; Azeddine Dellal; Marc Debernardi; Bernard Cortet; Françoise Debiais; Rose-Marie Javier; Thierry Thomas; Nadia Mehsen-Cetre; Martine Cohen-Solal; Elisabeth Fontanges; Michel Laroche; Valérie Porquet-Bordes; Christian Marcelli; Alexandra Benachi; Karine Briot; Christian Roux; Catherine Cormier

Orphanet Journal of Rare Diseases · 2022

© The Author(s) 2022https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T10:18:19.911687+00:00

DOI: 10.1186/s13023-021-02148-x · PMC8796450